Core Viewpoint - Bojie Co., Ltd. announced the transfer of its equity stakes in Suzhou Kunyuan Optoelectronics Co., Ltd., retaining a 4.47% ownership after the transaction, which is part of a strategy to recover investment costs and mitigate uncertainties related to equity investments [1][4]. Group 1: Company Overview - Suzhou Kunyuan was established in 2017 and focuses on the R&D, production, and sales of optoelectronic devices and other electronic components [1]. - The company is led by Dr. Chen Yiqiao, an expert from a national-level overseas high-level talent program, and has a team with extensive experience in molecular beam epitaxy (MBE) technology [2]. Group 2: Financial Performance - Suzhou Kunyuan reported revenues of 27.29 million yuan, 38.02 million yuan, and 55.04 million yuan for the years 2022, 2023, and 2024 respectively, indicating stable revenue growth [2]. - The company incurred net losses of 709,400 yuan and 605,280 yuan for the years 2024 and January-February 2025 [1][2]. Group 3: Investment Details - The equity stakes were sold for 20 million yuan and 7.69 million yuan, with the remaining stake valued at 14.43 yuan per share for one investor and 13.71 yuan per share for another [1][3]. - The transaction is expected to generate an estimated investment income of approximately 44.79 million yuan, with direct investment income of about 16.17 million yuan [4].
博杰股份转让参股公司股权 预计产生投资收益4479万元